The regulation and localization of angiopoietin-1, -2, and their receptor Tie2 in normal and pathologic human placentae

Molecular Medicine

Volumn 7, Issue 9, 2001, Pages 624-635

  Zhang, Echo G ^a   Smith, Stephen K ^a   Baker, Philip N ^a   Charnock Jones, D Stephen ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; DACTINOMYCIN; MESSENGER RNA; OXYGEN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPLANT; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; HYPOXIA; IN SITU HYBRIDIZATION; INTRAUTERINE GROWTH RETARDATION; NORTHERN BLOTTING; OXYGEN TENSION; PATHOLOGY; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REPRODUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNCYTIOTROPHOBLAST; TISSUE OXYGENATION;

EID: 0035718941     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401869     Document Type: Article

References (52)

1. Mechanisms of angiogenesis
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. What is the evidence that tumors are angiogenesis dependent?
4. Angiogenesis in cancer, vascular, rheumatoid and other disease
5. Angiogenic factors
6. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
7. Vascular permeability factor, an endothelial cell mitogen related to PDGF
8. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
9. Molecular and biological properties of the vascular endothelial growth factor family of proteins
10. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation
11. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
12. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
13. Alternative splicing of vascular endothelial growth factor (VEGF) - R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity
14. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation
15. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
16. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2
17. Increased vascularization in mice overexpressing angiopoietin-1
18. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
19. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
20. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization
21. Vascularization of the mouse embryo: A study of flk-1, tek, tie, and vascular endothelial growth factor expression during development
22. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
23. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
24. Pre-eclampsia: More than pregnancy-induced hypertension
25. Maternal mortality: Confidential enquiries into maternal deaths in the United Kingdom
26. Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy
27. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells
28. Blood vessel formation: What is its molecular basis?
29. Signaling vascular morphogenesis and maintenance
30. Human chorionic gonadotropin pattern in maternal circulation. Amniotic fluid and fetal circulation in late pregnancy
31. Immunofluorescent localization of placental lactogen, chorionic gonadotrophin and its alpha and beta subunits in organ cultures of human placenta
32. An immunohistological comparison of the secretory capacity of villous and extravillous trophoblast in the human placenta
33. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
34. Regulation of angiopoietin-2 mRNA levels in bovine
35. Variations in expression of copper/zinc superoxide dismutase in villous trophoblast of the human placenta with gestational age
36. Susceptibility of human placental syncytiotrophoblastic mitochondria to oxygen-mediated damage in relation to gestational age
37. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
38. Regulation of muscarinic receptor expression by changes in mRNA stability
39. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants
40. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies
41. Oxygen and placental villous development: Origins of fetal hypoxia
42. Stereological evaluation of vascular adaptations in human placental villi to differing forms of hypoxic stress
43. Histomorphometry of the human placenta in Class C diabetes mellitus
44. Histomorphometry of the human placenta in pre-eclampsia associated with severe intrauterine growth retardation
45. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development
46. Identification of HeLa gene markers in ED27 trophoblast-like cell lines isolated from first-trimester human chorionic villi
47. Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: A receptor ligand model for vascular remodeling
48. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia
49. Attachment and differentiation in vitro of trophoblast from normal and preeclamptic human placentas